Figures & data
Figure 1. Participation summary.
Table 1. Study participant demographics.
Table 2. Reported systemic adverse events prior to and following Influenza immunization
Table 3. Injection site reactions following Influenza vaccines.
Figure 2. Frequency and diameter of erythema at IDV injection sites at intervals following immunization.
Table 4. Comparison of immune responses to study vaccines at day 21 post-vaccination: HAI Assay.
Table 5. Comparison of immune responses to study vaccines at day 21 post-vaccination: SRH assay.
Table 6. Microneutralization titers to H3N2 virus at day 21–28 following vaccination: Groups of 100.
Figure 3. Seroprotection rates and 95% confidence intervals measured by HAI and SRH assays 21 and 180 d following immunization, for H1N1 and H3N2 antigens.
